Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Journal of Dentistry|August 23, 2005
The relationship between enamel softening and erosion caused by soft drinks at a range of temperaturesM E Barbour, M Finke, D M Parker, et al.
American Journal of Hematology|September 12, 2012
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosisRakhee Vaidya, Naseema Gangat, Thitina Jimma, et al.
Biochemistry|December 12, 2000
Commitment to folded and aggregated states occurs late in interleukin-1 beta foldingJ M Finke, L A Gross, H M Ho, et al.
Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.
Journal of Molecular Biology|April 7, 2005
The native energy landscape for interleukin-1beta. Modulation of the population ensemble through native-state topologyMelinda Roy, Leslie L Chavez, John M Finke, et al.
Blood|May 3, 2008
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignanciesReinhard Marks, Karin Potthoff, Joachim Hahn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 18, 2009
Synthesis and EPR studies of 2'-deoxyuridines with alkynyl, rodlike linkagesAdam Sniady, Michael D Sevilla, Srinivasarao Meneni, et al.
Annals of Hematology|April 24, 2016
Pruritus in primary myelofibrosis: management options in the era of JAK inhibitorsBrianna E Vaa, Ayalew Tefferi, Naseema Gangat, et al.
Biochimica Et Biophysica Acta. General Subjects|June 19, 2017
Antibody blood-brain barrier efflux is modulated by glycan modificationJohn M Finke, Kari R Ayres, Ryan P Brisbin, et al.
Leukemia|March 15, 2018
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctionsAyalew Tefferi, Christy M Finke, Terra L Lasho, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Journal of Dentistry|August 23, 2005
The relationship between enamel softening and erosion caused by soft drinks at a range of temperaturesM E Barbour, M Finke, D M Parker, et al.
American Journal of Hematology|September 12, 2012
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosisRakhee Vaidya, Naseema Gangat, Thitina Jimma, et al.
Biochemistry|December 12, 2000
Commitment to folded and aggregated states occurs late in interleukin-1 beta foldingJ M Finke, L A Gross, H M Ho, et al.
Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.
Journal of Molecular Biology|April 7, 2005
The native energy landscape for interleukin-1beta. Modulation of the population ensemble through native-state topologyMelinda Roy, Leslie L Chavez, John M Finke, et al.
Blood|May 3, 2008
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignanciesReinhard Marks, Karin Potthoff, Joachim Hahn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 18, 2009
Synthesis and EPR studies of 2'-deoxyuridines with alkynyl, rodlike linkagesAdam Sniady, Michael D Sevilla, Srinivasarao Meneni, et al.
Annals of Hematology|April 24, 2016
Pruritus in primary myelofibrosis: management options in the era of JAK inhibitorsBrianna E Vaa, Ayalew Tefferi, Naseema Gangat, et al.
Biochimica Et Biophysica Acta. General Subjects|June 19, 2017
Antibody blood-brain barrier efflux is modulated by glycan modificationJohn M Finke, Kari R Ayres, Ryan P Brisbin, et al.
Leukemia|March 15, 2018
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctionsAyalew Tefferi, Christy M Finke, Terra L Lasho, et al.
Pageof 18